{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:43:46Z","timestamp":1785300226561,"version":"3.55.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>Despite classic analgesic or effective treatments in rheumatic diseases, such as synthetic DMARDs in RA, patients remain in pain and often turn to non-prescribed pharmacological alternatives, such as cannabis self-therapeutic use. However, this medical use of cannabis has not been thoroughly studied.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed a systematic literature review up to June 2020. The incidence of cannabis consumption was calculated by metaproportion. Differences between cannabis users and non-users were expressed as standardized mean differences using the inverse-variance method. We also assessed the effects of cannabis on pain.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 2900 patients reported cannabis consumption in a sample of 10\u00a0873 patients [incidence 40.4% (95% confidence interval (CI): 0.28, 0.54)], and 15.3% (95% CI: 0.07, 0.27) specified that they were currently taking cannabis. Cannabis use was higher in the four fibromyalgia studies [68.2% (95% CI: 0.41, 0.90), n\u2009=\u2009611] compared with seven articles concerning RA or lupus [26.0% (95% CI: 0.14, 0.41), n\u2009=\u20098168]. Cannabis consumption was associated with a decrease in pain intensity [VAS pain at baseline 8.2 (2.9) vs 5.6 (3.5)\u2009mm over time; pooled effect size \u22121.75 (95% CI: \u22122.75, \u22120.76)]. Cannabis users were younger [58.4 (11.4) vs 63.6\u2009(12.1)\u2009years; P\u00a0&amp;lt;0.001], more often smokers [OR 2.91 (95% CI: 1.84, 4.60)] or unemployed [OR 2.40 (95% CI: 1.31, 4.40)], and had higher pain intensity [5.0 (2.4) vs 4.1(2.6)\u2009mm; P\u00a0&amp;lt;0.001] than non-users.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Nearly 20% of patients suffering from rheumatologic diseases actively consume cannabis, with an improvement in pain. The issue of cannabis use in the management of these patients should be addressed during medical consultation, essentially with cannabis-based standardized pharmaceutical products.<\/jats:p><\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa534","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T19:28:06Z","timestamp":1596569286000},"page":"549-556","source":"Crossref","is-referenced-by-count":26,"title":["Cannabis use assessment and its impact on pain in rheumatologic diseases: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"60","author":[{"given":"M","family":"Guillouard","sequence":"first","affiliation":[{"name":"Rheumatology Department, Clermont-Ferrand University Hospital, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Authier","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Clermont Auvergne, UMR INSERM 1107, CHU, Clermont-Ferrand, France"},{"name":"Institut ANALGESIA, Facult\u00e9 de M\u00e9decine, Clermont-Ferrand, France"},{"name":"Observatoire Fran\u00e7ais des M\u00e9dicaments Antalgiques (OFMA), French Monitoring Centre for Analgesic Drugs, CHU, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Pereira","sequence":"additional","affiliation":[{"name":"Biostatistics Unit (Clinical Research Direction), University Hospital of Clermont-Ferrand (CHU), Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Soubrier","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Clermont-Ferrand University Hospital, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Mathieu","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Clermont-Ferrand University Hospital, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,7]]},"reference":[{"key":"2021020119155059500_keaa534-B1","first-page":"430","article-title":"Effects of the oral Janus kinase inhibitor tofacitinib on patient-reported outcomes in patients with active rheumatoid arthritis: results of two Phase 2 randomised controlled trials","volume":"34","author":"Wallenstein","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"2021020119155059500_keaa534-B2","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1136\/annrheumdis-2017-211259","article-title":"Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study","volume":"76","author":"Keystone","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021020119155059500_keaa534-B3","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jpain.2007.10.018","article-title":"Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy","volume":"9","author":"Narang","year":"2008","journal-title":"J Pain"},{"key":"2021020119155059500_keaa534-B4","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1212\/WNL.0000000000000363","article-title":"Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"82","author":"Koppel","year":"2014","journal-title":"Neurology"},{"key":"2021020119155059500_keaa534-B5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/practneurol-2018-002137","article-title":"Cannabis and multiple sclerosis","volume":"19","author":"Ingram","year":"2019","journal-title":"Pract Neurol"},{"key":"2021020119155059500_keaa534-B6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/WNF.0000000000000246","article-title":"Medical cannabis in Parkinson disease: real-Life patients\u2019 experience","volume":"40","author":"Balash","year":"2017","journal-title":"Clin Neuropharmacol"},{"key":"2021020119155059500_keaa534-B7","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/jcm8111886","article-title":"Myorelaxant effect of transdermal cannabidiol application in patients with TMD: a randomized, double-blind trial","volume":"8","author":"Nitecka-Buchta","year":"2019","journal-title":"J Clin Med"},{"key":"2021020119155059500_keaa534-B8","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2125.2011.03970.x","article-title":"Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials","volume":"72","author":"Lynch","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"2021020119155059500_keaa534-B9","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1097\/j.pain.0000000000001052","article-title":"Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis","volume":"158","author":"Philpott","year":"2017","journal-title":"Pain"},{"key":"2021020119155059500_keaa534-B10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fvets.2018.00165","article-title":"Pharmacokinetics, safety, and clinical efficacy of cannabidiol treatment in osteoarthritic dogs","volume":"5","author":"Gamble","year":"2018","journal-title":"Front Vet Sci"},{"key":"2021020119155059500_keaa534-B11","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/acr.22727","article-title":"Efficacy, tolerability, and safety of cannabinoid treatments in the rheumatic diseases: a systematic review of randomized controlled trials","volume":"68","author":"Fitzcharles","year":"2016","journal-title":"Arthritis Care Res"},{"key":"2021020119155059500_keaa534-B12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.rhum.2019.03.009","article-title":"Le cannabis dans les douleurs musculosquelettiques et articulaires: des preuves sont n\u00e9cessaire","volume":"86","author":"Perrot","year":"2019","journal-title":"Rev Rheum"},{"key":"2021020119155059500_keaa534-B13","doi-asserted-by":"crossref","DOI":"10.1002\/acr.24176","article-title":"A cautious hope for cannabidiol (CBD) in rheumatology care","author":"Fitzcharles","year":"2020","journal-title":"Arthritis Care Res"},{"key":"2021020119155059500_keaa534-B14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"2021020119155059500_keaa534-B15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol Bull"},{"key":"2021020119155059500_keaa534-B16","article-title":"Efficacy of cannabis flos inpatients with fibromyalgia: a monocentric observational study. Arthritis Rheumatol","volume":"68","author":"Gerardi","year":"2016"},{"issue":"6","key":"2021020119155059500_keaa534-B17","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8060807","article-title":"Safety and efficacy of medical cannabis in fibromyalgia","author":"Sagy","year":"2019","journal-title":"J Clin Med"},{"key":"2021020119155059500_keaa534-B18","author":"Beck","year":"2016"},{"key":"2021020119155059500_keaa534-B19","first-page":"1825","article-title":"[Use of cannabis among adolescents and young adults in Norway]","volume":"128","author":"Pedersen","year":"2008","journal-title":"Tidsskr Nor Laegeforen"},{"key":"2021020119155059500_keaa534-B20","first-page":"35","article-title":"[Psychopathology of the cannabis user teenager]","volume":"55","author":"Corcos","year":"2005","journal-title":"Rev Prat"},{"key":"2021020119155059500_keaa534-B21","first-page":"70","article-title":"Alexithymia and psychological distress in fibromyalgia: prevalence and relation with quality of life","volume":"30","author":"Castelli","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"2021020119155059500_keaa534-B22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jad.2016.08.080","article-title":"Pain experience in Fibromyalgia Syndrome: the role of alexithymia and psychological distress","volume":"208","author":"Di Tella","year":"2017","journal-title":"J Affect Disord"},{"key":"2021020119155059500_keaa534-B23","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3390\/jcm7100336","article-title":"Sleep quality in patients with rheumatoid arthritis and associations with pain, disability, disease duration, and activity","volume":"7","author":"Grabovac","year":"2018","journal-title":"J Clin Med"},{"key":"2021020119155059500_keaa534-B24","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/acr.23593","article-title":"Sleep disturbance and depression symptoms mediate relationship between pain and cognitive dysfunction in lupus","volume":"71","author":"Lillis","year":"2019","journal-title":"Arthritis Care Res"},{"key":"2021020119155059500_keaa534-B25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/OARRR.S201556","article-title":"Frequency of sleep disorders in patients with rheumatoid arthritis","volume":"11","author":"Mustafa","year":"2019","journal-title":"Open Access Rheumatol"},{"key":"2021020119155059500_keaa534-B26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2105\/AJPH.2017.304050","article-title":"Trends in daily cannabis use among cigarette smokers: United States, 2002-2014","volume":"108","author":"Goodwin","year":"2018","journal-title":"Am J Public Health"},{"key":"2021020119155059500_keaa534-B27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.drugalcdep.2018.06.016","article-title":"Trends in cannabis use disorder by cigarette smoking status in the United States, 2002-2016","volume":"191","author":"Weinberger","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"2021020119155059500_keaa534-B28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00406-018-0976-1","article-title":"An update on cannabis use disorder with comment on the impact of policy related to therapeutic and recreational cannabis use","volume":"269","author":"Budney","year":"2019","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2021020119155059500_keaa534-B29","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s11121-020-01086-7","article-title":"Early and late adolescent factors that predict co-use of cannabis with alcohol and tobacco in young adulthood","volume":"21","author":"D\u2019Amico","year":"2020","journal-title":"Prev Sci"},{"key":"2021020119155059500_keaa534-B30","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3389\/fpsyt.2019.00821","article-title":"Longitudinal associations between the adolescent family environment and young adult substance use in Australia and the United States","volume":"10","author":"Heerde","year":"2019","journal-title":"Front Psychiatry"},{"key":"2021020119155059500_keaa534-B31","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.3109\/10826084.2014.933240","article-title":"Predictors of substance use among young adults transitioning away from high school: a narrative review","volume":"49","author":"Kirst","year":"2014","journal-title":"Subst Use Misuse"},{"key":"2021020119155059500_keaa534-B32","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1136\/annrheumdis-2013-204601","article-title":"Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial","volume":"74","author":"Saevarsdottir","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2021020119155059500_keaa534-B33","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/art.27388","article-title":"The effect of alcohol on radiographic progression in rheumatoid arthritis","volume":"62","author":"Nissen","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2021020119155059500_keaa534-B34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/1471-2474-14-218","article-title":"Alcohol consumption is associated with lower self-reported disease activity and better health-related quality of life in female rheumatoid arthritis patients in Sweden: data from BARFOT, a multicenter study on early RA","volume":"14","author":"Bergman","year":"2013","journal-title":"BMC Musculoskelet Disord"},{"key":"2021020119155059500_keaa534-B35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/014107689608900303","article-title":"Ought low alcohol intake to be promoted for health reasons?","volume":"89","author":"Holman","year":"1996","journal-title":"J R Soc Med"},{"key":"2021020119155059500_keaa534-B36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.15288\/jsad.2016.77.185","article-title":"Do \u201cModerate\u201d drinkers have reduced mortality risk? A systematic review and meta-analysis of alcohol consumption and all-cause mortality","volume":"77","author":"Stockwell","year":"2016","journal-title":"J Stud Alcohol Drugs"},{"key":"2021020119155059500_keaa534-B37","first-page":"916","article-title":"Evidence for benefit of low-dose alcohol","volume":"63","author":"Fernando","year":"2017","journal-title":"Can Fam Physician"},{"key":"2021020119155059500_keaa534-B38","doi-asserted-by":"crossref","first-page":"rkz039","DOI":"10.1093\/rap\/rkz039","article-title":"Discussions of lifestyle habits as an integral part of care management: a cross-sectional cohort study in patients with established rheumatoid arthritis in Sweden","volume":"3","author":"Malm","year":"2019","journal-title":"Rheumatol Adv Pract"},{"key":"2021020119155059500_keaa534-B39","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jhealeco.2017.08.005","article-title":"Unemployment, drugs and attitudes among European youth","volume":"57","author":"Ayll\u00f3n","year":"2018","journal-title":"J Health Econ"},{"key":"2021020119155059500_keaa534-B40","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1111\/j.1360-0443.1992.tb02665.x","article-title":"Unemployment and use of drug and alcohol among young people: a longitudinal study in the general population","volume":"87","author":"Hammer","year":"1992","journal-title":"Br J Addict"},{"key":"2021020119155059500_keaa534-B41","doi-asserted-by":"crossref","first-page":"e0222361","DOI":"10.1371\/journal.pone.0222361","article-title":"Alcohol, tobacco and cannabis use are associated with job loss at follow-up: findings from the CONSTANCES cohort","volume":"14","author":"Airagnes","year":"2019","journal-title":"PLoS One"},{"key":"2021020119155059500_keaa534-B42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.socscimed.2017.01.001","article-title":"Modelling possible causality in the associations between unemployment, cannabis use, and alcohol misuse","volume":"175","author":"Boden","year":"2017","journal-title":"Soc Sci Med"},{"key":"2021020119155059500_keaa534-B43","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1360-0443.2012.03796.x","article-title":"Does smoking cannabis affect work commitment?","volume":"107","author":"Hyggen","year":"2012","journal-title":"Addiction"},{"key":"2021020119155059500_keaa534-B44","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1111\/j.1360-0443.2011.03436.x","article-title":"Cannabis and social welfare assistance: a longitudinal study","volume":"106","author":"Pedersen","year":"2011","journal-title":"Addiction"},{"key":"2021020119155059500_keaa534-B45","first-page":"100188","article-title":"An inverse relationship between perceived social support and substance use frequency in socially stigmatized populations","volume":"10","author":"Rapier","year":"2019","journal-title":"Addict Behav Rep"},{"key":"2021020119155059500_keaa534-B46","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.drugalcdep.2016.10.022","article-title":"A longitudinal examination of the relationship between cannabis use and cognitive function in mid-life adults","volume":"169","author":"McKetin","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"2021020119155059500_keaa534-B47","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1089\/can.2016.0010","article-title":"Sex differences in cannabis use and effects: a cross-sectional survey of cannabis users","volume":"1","author":"Cuttler","year":"2016","journal-title":"Cannabis Cannabinoid Res"},{"key":"2021020119155059500_keaa534-B48","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejim.2018.01.019","article-title":"Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly","volume":"49","author":"Abuhasira","year":"2018","journal-title":"Eur J Intern Med"},{"key":"2021020119155059500_keaa534-B49","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1016\/S2468-2667(18)30110-5","article-title":"Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study","volume":"3","author":"Campbell","year":"2018","journal-title":"Lancet Public Health"},{"key":"2021020119155059500_keaa534-B50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.semarthrit.2017.01.005","article-title":"Frequency of concomitant fibromyalgia in rheumatic diseases: monocentric study of 691 patients","volume":"47","author":"Fan","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"2021020119155059500_keaa534-B51","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/s0304-3959(02)00400-1","article-title":"Cannabis use for chronic non-cancer pain: results of a prospective survey","volume":"102","author":"Ware","year":"2003","journal-title":"Pain"},{"key":"2021020119155059500_keaa534-B52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/7561209","article-title":"The consumption of cannabis by fibromyalgia patients in Israel","volume":"2018","author":"Habib","year":"2018","journal-title":"Pain Res Treat"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/2\/549\/36168048\/keaa534.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/2\/549\/36168048\/keaa534.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T08:08:41Z","timestamp":1696493321000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/2\/549\/5960204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,7]]},"references-count":52,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,11,7]]},"published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa534","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2020,11,7]]}}}